BioNTech SE
BNTX
$99.47
$2.012.06%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 887.91% | -31.98% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 887.91% | -31.98% | |||
| Cost of Revenue | 205.57% | 0.32% | |||
| Gross Profit | 1,480.14% | -46.84% | |||
| SG&A Expenses | -16.36% | 37.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 34.03% | 3,159.58% | |||
| Total Operating Expenses | 14.64% | 56.54% | |||
| Operating Income | 102.22% | -89.55% | |||
| Income Before Tax | 120.12% | -140.79% | |||
| Income Tax Expenses | -2,112.14% | 111.87% | |||
| Earnings from Continuing Operations | 125.05% | -154.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 125.05% | -154.18% | |||
| EBIT | 102.22% | -89.55% | |||
| EBITDA | 107.31% | -94.52% | |||
| EPS Basic | 124.93% | -154.31% | |||
| Normalized Basic EPS | 125.91% | -150.43% | |||
| EPS Diluted | 124.62% | -154.31% | |||
| Normalized Diluted EPS | 125.60% | -150.43% | |||
| Average Basic Shares Outstanding | 0.49% | -0.05% | |||
| Average Diluted Shares Outstanding | 1.73% | -0.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
